Trailblazer clinical trial featured in New York Times

Abington Neurological Associates is proud to have participated in the TRAILBLAZER-ALZ study that produced these results. We are currently conducting the phase 3 trial, TRAILBLAZER-ALZ-2.

In the narrow window in which patients are aware of their disease, they have sought help in clinical trials. But enrolling enough participants to make these trials count is not easy.